The data presented herein establish that the mRNA-binding and destabilizing protein TTP plays important roles in harnessing prostate cancer growth and tumorigenicity, and they suggest that reactivating TTP expression in aggressive prostate tumors, which express low levels of this protein, would be an effective means for disabling tumor metabolism. Here, ZFP36 is linked to neoplasm.